Topical Voltaren in Otitis Externa
Information source: Sieff Medical Center
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Otitis Externa
Intervention: diclofenac sodium (Drug); dexotc (Drug)
Phase: Phase 2
Status: Not yet recruiting
Sponsored by: Sieff Medical Center Official(s) and/or principal investigator(s):
victor kizhner, m.d., Principal Investigator, Affiliation: Sieff Medical Center, Safed, ISRAEL
Overall contact:
victor kizhner, m.d., Phone: +972-544705898, Email: vic466@zahav.net.il
Summary
voltaren being a NSAID drug may be used as a single drug therapy in otitis externa being both
therapeutic and analgesic thus reducing consumption of oral analgesia
Clinical Details
Official title: Topical Voltaren as an Alternative Treatment for Otitis Externa
Study design: Treatment, Randomized, Double Blind (Subject, Caregiver), Active Control, Parallel Assignment, Efficacy Study
Primary outcome: reducing oral analagestic use
Secondary outcome: adding an alternative treatment for otitis externa
Detailed description:
anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation-
when steroids are employed, contains boric acid as an ingredient, high safety profile, can be
switched to antibiotic therapy later, can be used in conjunction wit steroids
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Adults having otitis externa as single diagnosis mild to moderate
Exclusion Criteria:
- Diabetes
- Children
- Pregnant women
- Immune compromise
- Starting other treatment
- Moderate to severe otitis externa
Locations and Contacts
victor kizhner, m.d., Phone: +972-544705898, Email: vic466@zahav.net.il
Sieff Medical Center, Safed 13100, Israel
Additional Information
Sieff Medical Center
Starting date: September 2007
Last updated: August 28, 2007
|
